# BIND Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bind-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.bindtherapeutics.com
- Total disclosed funding: $76M
- Latest round: Series D (Jan 23, 2013)
- Investors on record: 7

## About

Founded in 2006 and based in Cambridge, Massachusetts, BIND Therapeuticw, Inc. operates as a biopharmaceutical company that focuses on developing therapeutic targeted nanoparticles for the treatment of cancer, inflammatory, infectious, and cardiovascular diseases.

## Funding rounds

- Series D, Jan 23, 2013, $8.7M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners
- Series D, Nov 22, 2011, $26M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners, Endeavour Vision, +ND Capital, RUSNANO Management Company, DHK Investments
- Series C, Jun 11, 2010, $12M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners, Endeavour Vision, +ND Capital, DHK Investments
- Series C, Jan 11, 2010, $11M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners, +ND Capital, DHK Investments
- Series B, Nov 14, 2007, $16M — ARCH Venture Partners, Flagship Pioneering, Polaris Partners, +ND Capital
- Series A, Jan 29, 2007, $1M — Flagship Pioneering, Polaris Partners
- Series A, Dec 13, 2006, $1.5M — Polaris Partners

## Investors

- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C, Series D
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B, Series C, Series D
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B, Series C, Series D
- +ND Capital (https://capitalatlas.ai/funds/nd-capital) — Series B, Series C, Series D
- DHK Investments — Series C, Series D
- Endeavour Vision (https://capitalatlas.ai/funds/endeavour-vision) — Series C, Series D
- RUSNANO Management Company — Series D